A new look at old problems: Ovarian function suppression in the real world

被引:1
|
作者
Sella, Tal [1 ]
Partridge, Ann H. [1 ]
机构
[1] Dana Farber Canc Inst, Dept Med Oncol, 450 Brookline Ave, Boston, MA 02215 USA
关键词
adherence; adjuvant therapy; breast cancer; hormonal therapy; ovarian function suppression; ADJUVANT ENDOCRINE THERAPY; POSITIVE BREAST-CANCER; PREMENOPAUSAL WOMEN; TAMOXIFEN; SURVIVAL; TRIAL;
D O I
10.1002/cncr.33368
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
There is concern that the addition of ovarian function suppression to the endocrine treatment of premenopausal patients with breast cancer will increase nonadherence to treatment in this population. Although nonadherence to oral endocrine therapy was fairly high in the first year in this study, it was not worse when it was combined with endocrine therapy.
引用
收藏
页码:1174 / 1176
页数:3
相关论文
共 50 条